Yew Bio-Pharm Group, Inc. Overview
Industry: Farm Products
Sector: Consumer Defensive
Yew Bio-Pharm Group, Inc., through its subsidiaries, grows and sells yew trees in the People's Republic of China and the United States. It offers traditional Chinese medicine (TCM) raw materials in the form of yew tree branches and leaves to manufacture TCM containing taxol. The company is also involved in processing and selling yew raw materials used in the manufacture of traditional Chinese medicine; growing and selling yew tree seedlings and mature trees, including potted miniature yew trees; manufacturing and selling furniture and handicrafts made of yew tree timber; selling agricultural products, such as yew candles, pine needle extracts, taxus cuspidate extracts, northeast yew extracts, and yew essential oil soaps; and selling wood ear mushroom. In addition, it engages in the marketing and sale of cosmetics. The company was incorporated in 2007 and is based in El Monte, California.
Yew Bio-Pharm Group, Inc. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review Yew Bio-Pharm Group, Inc. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
Yew Bio-Pharm Group, Inc. Competitors
Yew Bio-Pharm Group, Inc. operates in the Farm Products industry within the Consumer Defensive sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans